583 related articles for article (PubMed ID: 25504959)
1. Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors.
Marangoni RG; Korman BD; Wei J; Wood TA; Graham LV; Whitfield ML; Scherer PE; Tourtellotte WG; Varga J
Arthritis Rheumatol; 2015 Apr; 67(4):1062-73. PubMed ID: 25504959
[TBL] [Abstract][Full Text] [Related]
2. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?
Wei J; Melichian D; Komura K; Hinchcliff M; Lam AP; Lafyatis R; Gottardi CJ; MacDougald OA; Varga J
Arthritis Rheum; 2011 Jun; 63(6):1707-17. PubMed ID: 21370225
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue diseases: Adipocyte-myofibroblast transition: linking intradermal fat loss to skin fibrosis in SSc.
Onuora S
Nat Rev Rheumatol; 2015 Feb; 11(2):63. PubMed ID: 25561364
[No Abstract] [Full Text] [Related]
4. The roles of dermal white adipose tissue loss in scleroderma skin fibrosis.
Marangoni RG; Lu TT
Curr Opin Rheumatol; 2017 Nov; 29(6):585-590. PubMed ID: 28800024
[TBL] [Abstract][Full Text] [Related]
5. FIZZ1-induced myofibroblast transdifferentiation from adipocytes and its potential role in dermal fibrosis and lipoatrophy.
Martins V; Gonzalez De Los Santos F; Wu Z; Capelozzi V; Phan SH; Liu T
Am J Pathol; 2015 Oct; 185(10):2768-76. PubMed ID: 26261086
[TBL] [Abstract][Full Text] [Related]
6. CCN2 is required for bleomycin-induced skin fibrosis in mice.
Liu S; Shi-wen X; Abraham DJ; Leask A
Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
[TBL] [Abstract][Full Text] [Related]
7. Editorial: Fate of fat tissue adipocytes: do they transform into myofibroblasts in scleroderma?
Bogatkevich GS
Arthritis Rheumatol; 2015 Apr; 67(4):860-1. PubMed ID: 25504912
[No Abstract] [Full Text] [Related]
8. Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1.
Ohgo S; Hasegawa S; Hasebe Y; Mizutani H; Nakata S; Akamatsu H
Exp Dermatol; 2013 Nov; 22(11):769-71. PubMed ID: 24118261
[TBL] [Abstract][Full Text] [Related]
9. The nuclear receptor constitutive androstane receptor/NR1I3 enhances the profibrotic effects of transforming growth factor β and contributes to the development of experimental dermal fibrosis.
Avouac J; Palumbo-Zerr K; Ruzehaji N; Tomcik M; Zerr P; Dees C; Distler A; Beyer C; Schneider H; Distler O; Schett G; Allanore Y; Distler JH
Arthritis Rheumatol; 2014 Nov; 66(11):3140-50. PubMed ID: 25155144
[TBL] [Abstract][Full Text] [Related]
10. Scleroderma-like Impairment in the Network of Telocytes/CD34
Rosa I; Romano E; Fioretto BS; Guasti D; Ibba-Manneschi L; Matucci-Cerinic M; Manetti M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830288
[TBL] [Abstract][Full Text] [Related]
11. CD109 overexpression ameliorates skin fibrosis in a mouse model of bleomycin-induced scleroderma.
Vorstenbosch J; Al-Ajmi H; Winocour S; Trzeciak A; Lessard L; Philip A
Arthritis Rheum; 2013 May; 65(5):1378-83. PubMed ID: 23436317
[TBL] [Abstract][Full Text] [Related]
12. Alpha2-antiplasmin regulates the development of dermal fibrosis in mice by prostaglandin F(2α) synthesis through adipose triglyceride lipase/calcium-independent phospholipase A(2).
Kanno Y; Kawashita E; Kokado A; Okada K; Ueshima S; Matsuo O; Matsuno H
Arthritis Rheum; 2013 Feb; 65(2):492-502. PubMed ID: 23124680
[TBL] [Abstract][Full Text] [Related]
13. Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma.
Yang L; Serada S; Fujimoto M; Terao M; Kotobuki Y; Kitaba S; Matsui S; Kudo A; Naka T; Murota H; Katayama I
PLoS One; 2012; 7(7):e41994. PubMed ID: 22911870
[TBL] [Abstract][Full Text] [Related]
14. Animal model of sclerotic skin. V: Increased expression of alpha-smooth muscle actin in fibroblastic cells in bleomycin-induced scleroderma.
Yamamoto T; Nishioka K
Clin Immunol; 2002 Jan; 102(1):77-83. PubMed ID: 11781070
[TBL] [Abstract][Full Text] [Related]
15. Activation of pregnane X receptor inhibits experimental dermal fibrosis.
Beyer C; Skapenko A; Distler A; Dees C; Reichert H; Munoz L; Leipe J; Schulze-Koops H; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2013 Apr; 72(4):621-5. PubMed ID: 23291432
[TBL] [Abstract][Full Text] [Related]
16. An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis.
Yamashita T; Lakota K; Taniguchi T; Yoshizaki A; Sato S; Hong W; Zhou X; Sodin-Semrl S; Fang F; Asano Y; Varga J
Sci Rep; 2018 Aug; 8(1):11843. PubMed ID: 30087356
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.
Marangoni RG; Masui Y; Fang F; Korman B; Lord G; Lee J; Lakota K; Wei J; Scherer PE; Otvos L; Yamauchi T; Kubota N; Kadowaki T; Asano Y; Sato S; Tourtellotte WG; Varga J
Sci Rep; 2017 Jun; 7(1):4397. PubMed ID: 28667272
[TBL] [Abstract][Full Text] [Related]
18. Interfacial Adipose Tissue in Systemic Sclerosis.
Kruglikov IL
Curr Rheumatol Rep; 2017 Jan; 19(1):4. PubMed ID: 28138823
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypical analysis of myofibroblasts and mesenchymal cells in the bleomycin-induced rat scleroderma, with particular reference to their origin.
Juniantito V; Izawa T; Yuasa T; Ichikawa C; Tanaka M; Kuwamura M; Yamate J
Exp Toxicol Pathol; 2013 Jul; 65(5):567-77. PubMed ID: 22749686
[TBL] [Abstract][Full Text] [Related]
20. Myofibroblast transcriptome indicates SFRP2
Tabib T; Huang M; Morse N; Papazoglou A; Behera R; Jia M; Bulik M; Monier DE; Benos PV; Chen W; Domsic R; Lafyatis R
Nat Commun; 2021 Jul; 12(1):4384. PubMed ID: 34282151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
